NUS Chancellor, His Excellency Dr Tony Tan visits CSI

CSI Singapore had the great pleasure of welcoming our NUS Chancellor, His Excellency Dr Tony Tan Keng Yam, to the Institute on 15th May 2013, where...
READ MORE
RSK3/4 mediate resistance to PI3K pathway inhibitors in breast cancer (J Clin Invest, May 2013)

The PI3K signaling pathway regulates diverse cellular processes including proliferation, survival and metabolism and is aberrantly activated in...
READ MORE
Genomic and functional characterizations of phosphodiesterase subtype 4D in human cancers (Proc Natl Acad Sci U S A, April 2013)

Discovery of cancer genes through interrogation of genomic dosage is one of the major approaches in cancer research. In this study, we report that...
READ MORE